A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details

Hisanori Umehara(Kanazawa Medical University), Kazuichi Okazaki(Kansai Medical University), Yasufumi Masaki(Kanazawa Medical University), Mitsuhiro Kawano(Kanazawa University), Motohisa Yamamoto(Sapporo Medical University), Takako Saeki(Nagaoka Red Cross Hospital), Shoko Matsui(University of Toyama), Takayuki Sumida(University of Tsukuba), Tsuneyo Mimori(Kyoto University), Yoshiya Tanaka(University of Occupational and Environmental Health Japan), Kazuo Tsubota(Keio University), Tadashi Yoshino(Okayama University), Shigeyuki Kawa(Shinshu University), Ritsuro Suzuki(Nagoya University), Tsutomu Takegami(Kanazawa Medical University), Naohisa Tomosugi(Kanazawa Medical University), Nozomu Kurose(Kanazawa Medical University), Yasuhito Ishigaki(Kanazawa Medical University), Atsushi Azumi(Kobe Kaisei Hospital), Masaru Kojima(Dokkyo University), Shigeo Nakamura(Nagoya University Hospital), Dai Inoue(Kanazawa University)
Modern Rheumatology
February 1, 2012
Cited by 689Open Access
Full Text

Abstract

IgG4-related disease (IgG4RD) is a novel clinical disease entity characterized by elevated serum IgG4 concentration and tumefaction or tissue infiltration by IgG4-positive plasma cells. IgG4RD may be present in a certain proportion of patients with a wide variety of diseases, including Mikulicz's disease, autoimmune pancreatitis, hypophysitis, Riedel thyroiditis, interstitial pneumonitis, interstitial nephritis, prostatitis, lymphadenopathy, retroperitoneal fibrosis, inflammatory aortic aneurysm, and inflammatory pseudotumor. Although IgG4RD forms a distinct, clinically independent disease category and is attracting strong attention as a new clinical entity, many questions and problems still remain to be elucidated, including its pathogenesis, the establishment of diagnostic criteria, and the role of IgG4. Here we describe the concept of IgG4RD and up-to-date information on this emerging disease entity.


Related Papers